Getting Pitch Perfect
Pitching to investors has changed a lot since the pandemic. Buzzkill Founder and CTO George Farquar characterizes it as more of a conversation than a formal pitch. He and Buzzkill’s CEO, Jeff Heimburger, recently raised an oversubscribed Series A. They will give their pitch and break down the process in this Lunch and Learn Master Class.
Questions in advance? Email us at info@daybreaklabs.io.
About The Master Class Instructors
Buzzkill Labs, a Daybreak Labs alum, is a sensor company that is modernizing drug testing in a legalized world. Their first product is a rapid saliva test for THC. This test is sorely needed by employers who need to make sure prospective and existing employees are “drug-free” enough to work as more and more states legalize the use of marijuana and THC products. Buzzkill Labs recently closed an oversubscribed Series A round in a very difficult market, in part due to the enormous market need for their THC saliva test.
George brings over 20 years of analytical chemistry experience, including 10 years at Lawrence Livermore National Laboratory where he developed solutions for detecting trace chemicals using a variety of chemistry techniques. He earned his Ph.D. from Louisiana State University.
Jeff has over 25 years of experience developing and commercializing disruptive technologies in the diagnostics, life science and forensic markets. He led the largest global business unit in molecular diagnostics with $700M P&L. Jeff successfully launched dozens of products into regulated markets worldwide, including instruments, consumables and services.
Buzzkill Labs is developing next generation technology that combines patented noninvasive sample collection methodology with scientifically validated laboratory detection and quantitation technology. Buzzkill Labs products address the growing need for safety in the work place. Learn more at buzzkilllabs.com. Listen to our interview with George and Jeff on the Startup Tri-Valley Podcast.